跳至主要内容
临床试验/EUCTR2020-001325-31-NL
EUCTR2020-001325-31-NL进行中(未招募)1 期

[68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of activated endothelium in lung parenchyma of COVID-19 patients. - RDG-PET/CT imaging in COVID-19 patients.

Radboud University Medical Center0 个研究点目标入组 10 人开始时间: 2020年4月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • A microbiologically proven SARS-CoV-19 infection;
  • Pulmonary involvement as demonstrated on recent (<1 week) chest CT;
  • Enrolled in the BioMarCo-19 study (CMO2020-6344);
  • More than or equal to 18 years of age;
  • Ability to provide written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 3
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 7

排除标准

  • Contra-indication for PET:
  • o Pregnancy;
  • o Breast-feeding;
  • o Severe claustrophobia.
  • Contra-indication for administration of iodine-containing contrast agents;
  • Other serious illness, e.g. history of malignancies
  • ;• Estimated creatinine clearance = 30 mL/min according to the Cockcroft-Gault formula (or local institutional standard method).

研究者

相似试验